Ying Yue
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Ovarian cancer diagnosis and treatment 5
Ying Yue
70 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Immunology 377
- Cancer Research 230
- Oncology 295
- Biomaterials 114
- Molecular Biology 568
Countries citing papers authored by Ying Yue
This map shows the geographic impact of Ying Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Yue more than expected).
Fields of papers citing papers by Ying Yue
This network shows the impact of papers produced by Ying Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Yue. The network helps show where Ying Yue may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Yue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 11 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 13 | |
| 12 | 2021 | 82 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 5 | |
| 16 | 2018 | 28 | |
| 17 | 2018 | 8 | |
| 18 | 2015 | 89 | |
| 19 | Knockdown of STAT3 by iRNA Inhibiting Migration and Invasion of Epithelial Ovarian Cancer Cells | 2012 | 1 |
| 20 | Effect of Liuweiwuling tablets combined with adefovir dipivoxil for chronic hepatitis B patients | 2011 | 1 |
About Ying Yue
Ying Yue is a scholar working on Hepatology, Reproductive Medicine, Immunology, Cancer Research and Transplantation, having authored 76 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (6 papers), IL-33, ST2, and ILC Pathways (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Hepatitis B Virus Studies (5 papers), Eosinophilic Esophagitis (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Immunology (377 citations), Cancer Research (230 citations), Oncology (295 citations), Biomaterials (114 citations) and Molecular Biology (568 citations). Ying Yue has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi Zhang, Jingyao Lian, Weina Yu, Mingyue Zhang, Shan Zong, Wenhong Zhang, Jingwen Ai, Xian Zhou, Yiyi Qian and Honglong Wu. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Infectious Diseases of Poverty, Frontiers in Cellular and Infection Microbiology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.